COLORECTAL

Clinical trials for COLORECTAL explained in plain language.

Never miss a new study

Get alerted when new COLORECTAL trials appear

Sign up with your email to follow new studies for COLORECTAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 5 Not yet finished but already full! 1

Engineered immune cells take on Hard-to-Treat cancers in early trial

Disease control Ongoing

This early-stage trial tests a personalized cell therapy for people with advanced colorectal, pancreatic, or lung cancers that have a specific KRAS G12V mutation. The treatment involves taking a patient's own immune T cells, engineering them to recognize and attack cancer cells, …

Matched conditions: COLORECTAL

Phase: PHASE1 • Sponsor: Corregene Biotechnology Co., Ltd • Aim: Disease control

Last updated Jun 27, 2026 12:00 UTC

COLORECTAL

Get alerted when new COLORECTAL trials appear

Engineered immune cells take on Hard-to-Treat cancers in early trial